Stock listing

Cboe Canada:NIRV.X Nirvana Life Sciences Inc Stock

Canadian listing (Cboe Canada) of Nirvana Life Sciences Inc · home listing CSE:NIRV.X

Follow Nirvana Life Sciences Inc into a list and get an email when it puts out news.

Home listing price · CSE:NIRV.X

$0.05 CAD 0.00 (0.0%)

Close on Oct 15, 2026 · This listing has no price on 6ix; the price shown is the home listing's, CSE:NIRV.X · Data provided by Twelve Data

Ticker: Cboe Canada:NIRV.X
Asset type: Stock
Sector: Health care
Industry: Biotechnology
Exchange: Cboe Canada
Currency: CAD

Latest news

Nirvana Life Sciences Inc. Announces Receipt of First North American Production of SOSA, a Patented, WHO Approved, Herbal Treatment for Opiate Addiction

Jan 29, 2024

Nirvana Life Sciences Inc. announces agreement to acquire the licensed distributor of a Patented, WHO approved, herbal treatment for opiate addiction

Nov 21, 2022

Nirvana Life Sciences Inc. Deuterates 7-Hydroxymitragynine to Create D7-h, an Analogue that May Improve Research and Formulations using Kratom Derivatives

Sep 22, 2022

Nirvana Life Sciences Inc. Announces a Method for Producing MDMA that Reduces Manufacturing Time by Two Thirds

Sep 7, 2022

Nirvana Life Sciences Inc. Announces License for a Delivery System for Psychedelic APIs

Jul 6, 2022

Nirvana Life Sciences Announces Approval To Build Vancouver Facility From Health Canada

Jun 28, 2022

Nirvana Life Sciences announces filing of Patent for novel isolation of 4-PO-Psilocin Prodrug Compound

Jun 23, 2022

Nirvana Life Sciences Announces Patent Filing

Jun 9, 2022

Nirvana Life Sciences Announces Positive Results for Addiction Relapse Prevention from Their Latest Pre-Clinical Psychedelic Drug Study

Jun 2, 2022

Nirvana Life Sciences Inc. Announces the appointment of Andrew Samann to Advisory Board

Apr 5, 2022

All Nirvana Life Sciences Inc news

Decks

Investor Presentation (April 2022)
Investor deck · 23 slides · April 2022
Investor Presentation (March 2022)
Investor deck · 24 slides · March 2022
Investor Presentation (March 2022)
Investor deck · 24 slides · March 2022
Investor Presentation (December 2021)
Investor deck · 26 slides · December 2021

Nirvana Life Sciences Inc on 6ix

Sector: Health care
Industry: Biotechnology
News releases: 11 in all · newest Jan 29, 2024 · oldest 2022
Decks: 4 decks · latest April 2022

Where Nirvana Life Sciences Inc is listed

Listing	Exchange	Country	Currency
CSE:NIRV.X · Home listing	CSE	Canada	CAD
OTC:NIRVF	OTC	United States	USD
Cboe Canada:NIRV.X · This page	Cboe Canada	Canada	CAD